Provided by Tiger Fintech (Singapore) Pte. Ltd.

HIGHTIDE-B

3.390
+0.2407.62%
Volume:2.21M
Turnover:7.40M
Market Cap:1.94B
PE:-3.68
High:3.420
Open:3.180
Low:3.180
Close:3.150
52wk High:3.920
52wk Low:0.720
Shares:571.00M
HK Float Shares:571.00M
Volume Ratio:1.88
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.920
ROE:-67.76%
ROA:-41.03%
PB:4.19
PE(LYR):-3.68
PS:51.92

Loading ...

Company Profile

Company Name:
HIGHTIDE-B
Exchange:
SEHK
Establishment Date:
2011
Employees:
70
Office Location:
Shenzhen-Hong Kong,Floor 9 to 10, Building D,Science and Technology Innovation Cooperation Zn,Fubao Community, Fubao Sub-district, Futian Distri,Shenzhen,Guangdong Province,China
Zip Code:
518112
Fax:
- -
Introduction:
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The Company has developed a product pipeline of multiple product candidates in-house, covering many indications in metabolic and digestive diseases among which, some are at clinical-stage. The Company’s core product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases. The Company conducts operations in the United States, Mainland China, Hong Kong and Australia.

Directors

Name
Position
LIU Li Ping
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
YU Meng
Executive Director
TAN Bo
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
Li Jin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
KONG De Wei
Independent Director,Member of the Nomination Committee,Audit Committee Member
ZHU Xun
Director
MA Li Xiong
Director
JIANG Feng
Director

Shareholders

Name
Position
LIU Li Ping
CEO
YU Meng
Vice General Manager
YU Li
Vice General Manager
ZHU Bi Min
Corporate Secretary
GAO Li Ping
Corporate Secretary
Leigh Anne MACCONELL
Other Senior Executives
MA Tian Wei
Other Senior Executives
BAI Ru
Other Senior Executives